ArticleJournal of robotic surgery2025
Predicting hemorrhagic complications in robotic-assisted partial nephrectomy for renal tumors: simplifying risk assessment with tumor diameter and depth.
Article in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07232927 (Evaluation of Hemostatic Agents in Partial Nephrectomy), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Evaluation of Hemostatic Agents in Partial Nephrectomy: A Prospective Randomized Trial
Who cites it
1 citing paper in PubMed.
- Perioperative blood loss in robotic urologic surgery: a retrospective evaluation of estimation methods.Journal of robotic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeRobotic-assisted partial nephrectomy has emerged as the standard surgical procedure for managing localized kidney cancers, with bleeding risk being a primary clinical consideration. This investigation seeks to establish simple predictive indicators for hemorrhage-related adverse events. MATERIALS AND
methodsWe performed a retrospective review of sequential patients undergoing robotic-assisted partial nephrectomy at a single tertiary medical center. Patient records and radiographic studies were analyzed to obtain clinical parameters. Tumor characteristics (size, infiltration depth, and standardized nephrometry measurements) were assessed by an experienced radiologist. Bleeding-related outcomes included surgical blood loss, transfusion requirements, reoperation, and need for angiographic intervention. Predictive factors for hemorrhagic events were examined statistically.
resultsThe study included 260 participants. Median nephrometry scores were 8.5 (PADUA) and 7.0 (RENAL). The average tumor size measured 39.1 mm with a mean penetration depth of 2.02 mm, and the median renal ischemia duration was 25.5 min. Mean operative hemorrhage volume was 147 ml. Transfusion was administered to 12.7% of cases, with 3.5% experiencing significant hemorrhagic complications. Tumor size independently predicted both intraoperative bleeding and transfusion needs, while invasion depth showed a strong association with severe bleeding events.
conclusionsCompared to comprehensive nephrometry systems, basic tumor measurements (diameter and depth) effectively anticipate bleeding risks. These straightforward parameters enable clinicians to identify high-risk patients and initiate preventive measures.
Indexed as
Identifiers
40637905What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.